Regencell Bioscience Holdings Limited
NasdaqCM:RGC
Sector
Industries
Location
Market Cap
USD 7.14 B
Share Price
USD 14.43
Avg Daily Volume
2,502,483
Change (1 day)
3.89%
Change (1 year)
30.83%
Change (YTD)
192.10%
Regencell Bioscience Holdings Limited Operating Cash Flow for the Trailing 12 Months (TTM) ending August 02, 2025: N/A
Regencell Bioscience Holdings Limited Operating Cash Flow is NA for the Trailing 12 Months (TTM) ending August 02, 2025. Operating cash flow is cash generated from the company’s regular business operations.
StockViz
Competitors
National CineMedia, Inc.
USD 4.80
NCMI
-0.05
-1.03%
Cinemark Holdings, Inc.
USD 27.25
CNK
-0.42
-1.52%
Phibro Animal Health Corporation
USD 27.92
PAHC
-0.09
-0.32%
Regis Corporation
USD 19.13
RGS
-0.62
-3.14%
RenovoRx, Inc.
USD 1.20
RNXT
-0.02
-1.64%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|